2025-09-05 12:06:19 pm | Source: Motilal Oswal Financial Services Ltd
Company Update : Apollo Hospitals Ltd By Motilal Oswal Financial Services Ltd

Robust growth in revenue; EBITDA/PAT exceed estimates
- Apollo Hospitals’ (APHS) 1QFY26 revenue grew 15% YoY to INR58.4b (est. INR57.3b).
- Healthcare services revenue grew 11% YoY to INR29.4b. HealthCo revenue rose 18.7% YoY to INR24.7b. AHLL revenue grew 18.8% YoY to INR4.4b.
- EBITDA margin expanded by 130bp YoY to 14.6% (our est. 13.6%) due to lower employee costs and other expenses (22bp/117bp YoY as % sales), offset by an increase in RM costs (26bp YoY as % sales).
- EBITDA grew 26.2% YoY to INR8.5b (surpassing our estimate of INR7.8b).
- Adj. PAT grew 41.8% YoY to INR4.3b (our est: INR3.8b). Hospital segment highlights:
- Hospital EBITDA grew 15% YoY to INR7.2b and EBITDA margin expanded 90bp YoY to 24.5%.
- Average revenue per patient rose 9% YoY to INR172,282.
- Occupancy stood at 65% vs. 68% in 1QFY25.
- ALOS decreased by 6% to 3.1 days.
HealthCo performance snapshot:
- HealthCo reported EBITDA of INR940m vs. INR230m in 1QFY25. EBITDA margins stood at 3.8%.
- Platform GMV grew 23% YoY to INR6.8b. ? A total of 6,742 operating stores as of 1QFY26.
AHLL segment highlight:
- Revenue/EBITDA grew by 19%/31% YoY to INR4.4b/INR400m.
- Revenue of primary care increased by 17% YoY to INR1.1b.
- Revenue of specialty care rose 9% YoY to INR1.9b.
- Network collection centers increased by 65 centers YoY to 2173 centers.
Other highlights
- APHS is on track to add 4370 beds through acquisitions and brownfield and greenfield expansions over the next 3-4 years in India.
For More Research Reports : Click Here
For More Motilal Oswal Securities Ltd Disclaimer
http://www.motilaloswal.com/MOSLdisclaimer/disclaimer.html
SEBI Registration number is INH000000412
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News

Buy Vishal Mega Mart Ltd for the Target Rs.170 by Mo...

Buy Max Healthcare Ltd for the Target Rs. 1,450 by M...

Neutral BPCL Ltd for the Target Rs. 310 by Motilal O...

Buy Ashok Leyland Ltd for the Target Rs. 141 by Moti...

Neutral BPCL Ltd for the Target Rs. 327 by Motilal ...

`SEMICON India 2025` showcases India`s rise in globa...

India demonstrates potential to gasify coal with hig...

GST reforms to help textiles sector reach $350 billi...

GST cut a 200 bps demand upshift for 2-wheelers, 100...

GST reforms to boost dairy sector, benefit over 8 cr...